Kewaunee Scientific Reports Strong Sales Growth

Kewaunee Scientific ( (KEQU) ) has released its Q3 earnings. Here is a breakdown of the information Kewaunee Scientific presented to its investors.

Kewaunee Scientific Corporation is a global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, serving diverse industries with a strong presence in both domestic and international markets.

In its third quarter of fiscal year 2025, Kewaunee Scientific reported significant sales growth, driven by the successful acquisition of Nu Aire, Inc., which contributed to the company’s strategic expansion and operational performance.

The company experienced a 43.6% increase in sales, reaching $67.2 million, although pre-tax earnings decreased by 63.7% due to acquisition-related costs. Adjusted metrics showed improved performance, with adjusted pre-tax earnings rising by 7.8% and adjusted EBITDA increasing significantly. The domestic segment saw a substantial sales increase of 63.6%, while international sales grew modestly by 1.2%.

Despite the challenges in the international segment due to customer site delays, Kewaunee’s order backlog reached a robust $221.6 million, reflecting strong demand across various sectors. The company’s strategic focus on strengthening its supply chain and investing in manufacturing assets positions it well for future growth.

Looking ahead, Kewaunee Scientific remains committed to operational excellence and sustainable growth, with a clear strategic vision to capitalize on future opportunities and create lasting value for shareholders.